Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation.

Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study. PLoS One (2016) 0.75

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83

Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med (2012) 6.30

Chronic graft-versus-host disease. Biol Blood Marrow Transplant (2003) 5.36

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood (2011) 4.03

Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol (1991) 3.21

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood (2011) 2.87

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol (2001) 2.69

Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant (2001) 1.82

Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med (2011) 1.75

The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol (1989) 1.34

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant (1998) 1.27

Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea (2003) 1.25

A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci (2001) 1.25

Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant (1996) 1.24

Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea (2010) 1.16

Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant (2012) 1.16

Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea (2012) 1.10

Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol (2012) 1.07

Evaluation of the Schirmer Tear Test. South Med J (1970) 1.05

Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant (2007) 1.05

Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology (2009) 1.04

International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep (2013) 0.99

Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2007) 0.99

Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res (2007) 0.96

Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2006) 0.96

Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. Am J Pathol (2009) 0.91

Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol (2004) 0.90

Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf (2005) 0.90

Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients. Acta Ophthalmol (2013) 0.88

Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome. Biol Blood Marrow Transplant (2014) 0.88

Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Br J Haematol (2007) 0.87

Diabetes mellitus after hematopoietic stem cell transplantation. Endocr Pract (2010) 0.86

Visual acuity and anterior segment findings in chronic graft-versus-host disease. Cornea (2011) 0.84

Diabetes as an outcome predictor after heart transplantation. Interact Cardiovasc Thorac Surg (2011) 0.84

Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant (2006) 0.83

Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation. Cornea (2013) 0.80

Impact of preexisting diabetes mellitus on transplantation outcomes in hematopoietic stem cell transplantation. Endocr Res (2014) 0.79